Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
USE OF RESLIZUMAB TO TREAT MODERATE TO SEVERE EOSINOPHILIC ASTHMA

No-Receipt date 2020-03030 - 13/08/2020
No-Filing date 20200402289 - 13/08/2020
No-Granting date 3104734 - 08/09/2020
No-EPO application date 15760590.8 - 28/08/2015
No-EPO granting date 3191513 - 24/06/2020
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 9/2020 - 14/10/2020
Expiration date 29/08/2035
Kind of title Validation of European Patent
Legal status VALID
Priorities US201462047248 P08/09/2014/US
US201462091150 P12/12/2014/US
US201562168007 P29/05/2015/US
US201562191690 P13/07/2015/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
C07K 16/24

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1207761 CEPHALON, INC. 41 MOORES ROAD P.O. BOX 4011FRAZER, PA 19355 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
3073625 BRUSSELLE, GUY
3073626 O"BRIEN, CHRISTOPHER
3073627 ZANGRILLI, JAMES
3073628 SHAH, TUSHAR

Representatives
CodeFirstnameSurnameAddressTownZip
3614AIKATERINISIOTOU "KATERINA SIOTOU KAI SYNERGATES DIKIGORIKI ETAIREIA"PATISION (28IS OKTOVRIOU) 122ATHINA (ATTIKIS)11257

Contact
CodeFirstnameSurnameAddressTownZipCountry
4766AIKATERINISIOTOUPATISION (28IS OKTOVRIOU) 122ATHINA (ATTIKIS)11257 GREECE

Owners History

Title Instruments

Payments history 10 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015